AMP-dependent kinase inhibits oxidative stress-induced caveolin-1 phosphorylation and endocytosis by suppressing the dissociation between c-Abl and Prdx1 proteins in endothelial cells

Journal of Biological Chemistry

Volumn 288, Issue 28, 2013, Pages 20581-20591

  Takeuchi, Kimio ^a   Morizane, Yuki ^a,b   Kamami Levy, Cynthia ^a   Suzuki, Jun ^a   Kayama, Maki ^a   Cai, Wenyi ^a   Miller, Joan W ^a   Vavvas, Demetrios G ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CO-IMMUNOPRECIPITATION EXPERIMENTS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; PHARMACOLOGICAL ACTIVATOR; REGULATORY MECHANISM; SCAFFOLDING PROTEINS; SIGNALING MOLECULES; SPECIFIC INHIBITORS; STRUCTURAL COMPONENT;

CHEMICAL ACTIVATION; DISSOCIATION; ENDOTHELIAL CELLS; ENZYMES; MOLECULAR BIOLOGY; OXIDANTS; OXIDATIVE STRESS; PROTEINS; SCAFFOLDS (BIOLOGY);

PHOSPHORYLATION;

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; 5 IODOTUBERICIDIN; ABELSON KINASE; CAVEOLIN 1; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIPYRIDAMOLE; IMATINIB; OXIDIZING AGENT; PEROXIREDOXIN 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; BLOOD VESSEL PERMEABILITY; CELL PROTECTION; CONTROLLED STUDY; ENDOCYTOSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HOMEOSTASIS; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; UMBILICAL VEIN ENDOTHELIAL CELL;

AMP-ACTIVATED KINASE (AMPK); CAVEOLAE; CAVEOLIN; ENDOCYTOSIS; OXIDATIVE STRESS;

ALBUMINS; AMINOIMIDAZOLE CARBOXAMIDE; AMP-ACTIVATED PROTEIN KINASES; BLOTTING, WESTERN; CAVEOLIN 1; CELLS, CULTURED; DIPYRIDAMOLE; ENDOCYTOSIS; ENZYME ACTIVATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYDROGEN PEROXIDE; ISOENZYMES; MICROSCOPY, CONFOCAL; OXIDANTS; OXIDATIVE STRESS; PEROXIREDOXINS; PHOSPHORYLATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-ABL; RIBONUCLEOTIDES; RNA INTERFERENCE; TUBERCIDIN;

EID: 84880057785     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.460832     Document Type: Article

References (52)

1. Mehta, D., and Malik, A. B. (2006) Signaling mechanisms regulating endothelial permeability. Physiol. Rev. 86, 279-367
2. Sun, Y., Minshall, R. D., and Hu, G. (2011) Role of caveolin-1 in the regulation of pulmonary endothelial permeability. Methods Mol. Biol. 763, 303-317
3. Minshall, R. D., Sessa, W. C., Stan, R. V., Anderson, R. G., and Malik, A. B. (2003) Caveolin regulation of endothelial function. Am. J. Physiol. Lung Cell Mol. Physiol. 285, L1179-L1183 (Pubitemid 37448786)
4. Komarova, Y., and Malik, A. B. (2010) Regulation of endothelial permeability via paracellular and transcellular transport pathways. Annu. Rev. Physiol. 72, 463-493
5. Razani, B., Engelman, J. A., Wang, X. B., Schubert, W., Zhang, X. L., Marks, C. B., Macaluso, F., Russell, R. G., Li, M., Pestell, R. G., Di Vizio, D., Hou, H., Jr., Kneitz, B., Lagaud, G., Christ, G. J., Edelmann, W., and Lisanti, M. P. (2001) Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J. Biol. Chem. 276, 38121-38138
6. Drab, M., Verkade, P., Elger, M., Kasper, M., Lohn, M., Lauterbach, B., Menne, J., Lindschau, C., Mende, F., Luft, F. C., Schedl, A., Haller, H., and Kurzchalia, T. V. (2001) Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293, 2449-2452 (Pubitemid 32917325)
7. Hu, G., and Minshall, R. D. (2009) Regulation of transendothelial permeability by Src kinase. Microvasc. Res. 77, 21-25
8. Hardie, D. G., and Hawley, S. A. (2001) AMP-activated protein kinase. The energy charge hypothesis revisited. Bioessays 23, 1112-1119
9. Viollet, B., Athea, Y., Mounier, R., Guigas, B., Zarrinpashneh, E., Horman, S., Lantier, L., Hebrard, S., Devin-Leclerc, J., Beauloye, C., Foretz, M., Andreelli, F., Ventura-Clapier, R., and Bertrand, L. (2009) AMPK. Lessons from transgenic and knockout animals. Front. Biosci. 14, 19-44
10. Wang, W., and Guan, K. L. (2009) AMP-activated protein kinase and cancer. Acta Physiol (Oxf) 196, 55-63
11. Theodoropoulou, S., Kolovou, P. E., Morizane, Y., Kayama, M., Nicolaou, F., Miller, J. W., Gragoudas, E., Ksander, B. R., and Vavvas, D. G. (2010) Retinoblastoma cells are inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase. FASEB J. 24, 2620-2630
12. Theodoropoulou, S., Brodowska, K., Kayama, M., Morizane, Y., Miller, J. W., Gragoudas, E. S., and Vavvas, D. G. (2013) Aminoimidazole carboxamide ribonucleotide (AICAR) inhibits the growth of retinoblastoma in vivo by decreasing angiogenesis and inducing apoptosis. PLoS ONE 8, e52852
13. Suzuki, J., Manola, A., Murakami, Y., Morizane, Y., Takeuchi, K., Kayama, M., Miller, J. W., Sobrin, L., and Vavvas, D. G. (2011) Inhibitory effect of aminoimidazole carboxamide ribonucleotide (AICAR) on endotoxin-induced uveitis in rats. Invest. Ophthalmol. Vis. Sci. 52, 6565-6571
14. Suzuki, J., Yoshimura, T., Simeonova, M., Takeuchi, K., Murakami, Y., Morizane, Y., Miller, J. W., Sobrin, L., and Vavvas, D. G. (2012) Aminoimidazole carboxamide ribonucleotide ameliorates experimental autoimmune uveitis. Invest Ophthalmol Vis. Sci. 53, 4158-4169
15. Morizane, Y., Thanos, A., Takeuchi, K., Murakami, Y., Kayama, M., Trichonas, G., Miller, J., Foretz, M., Viollet, B., and Vavvas, D. G. (2011) AMP-activated protein kinase suppresses matrix metalloproteinase-9 expression in mouse embryonic fibroblasts. J. Biol. Chem. 286, 16030-16038
16. Creighton, J., Jian, M., Sayner, S., Alexeyev, M., and Insel, P. A. (2011) Adenosine monophosphate-activated kinase α1 promotes endothelial barrier repair. FASEB J. 25, 3356-3365
17. Volonté, D., Galbiati, F., Pestell, R. G., and Lisanti, M. P. (2001) Cellular stress induces the tyrosine phosphorylation of caveolin-1 (Tyr-14) via activation of p38 mitogen-activated protein kinase and c-Src kinase. Evidence for caveolae, the actin cytoskeleton, and focal adhesions as mechanical sensors of osmotic stress. J. Biol. Chem. 276, 8094-8103
18. Aoki, T., Nomura, R., and Fujimoto, T. (1999) Tyrosine phosphorylation of caveolin-1 in the endothelium. Exp. Cell Res. 253, 629-636 (Pubitemid 30003124)
19. Sanguinetti, A. R., and Mastick, C. C. (2003) c-Abl is required for oxidative stress-induced phosphorylation of caveolin-1 on tyrosine 14. Cell. Signal. 15, 289-298 (Pubitemid 36071673)
20. Sun, Y., Hu, G., Zhang, X., and Minshall, R. D. (2009) Phosphorylation of caveolin-1 regulates oxidant-induced pulmonary vascular permeability via paracellular and transcellular pathways. Circ. Res. 105, 676-685
21. Guigas, B., Bertrand, L., Taleux, N., Foretz, M., Wiernsperger, N., Vertommen, D., Andreelli, F., Viollet, B., and Hue, L. (2006) 5-Aminoimidazole- 4-carboxamide-1-β-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation. Diabetes 55, 865-874 (Pubitemid 44100158)
22. Guigas, B., Taleux, N., Foretz, M., Detaille, D., Andreelli, F., Viollet, B., and Hue, L. (2007) AMP-activated protein kinase-independent inhibition of hepatic mitochondrial oxidative phosphorylation by AICA riboside. Biochem. J. 404, 499-507 (Pubitemid 46953924)
23. Mukhtar, M. H., Payne, V. A., Arden, C., Harbottle, A., Khan, S., Lange, A. J., and Agius, L. (2008) Inhibition of glucokinase translocation by AMP-activated protein kinase is associated with phosphorylation of both GKRP and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294, R766-R774 (Pubitemid 351346952)
24. Foretz, M., Hébrard, S., Leclerc, J., Zarrinpashneh, E., Soty, M., Mithieux, G., Sakamoto, K., Andreelli, F., and Viollet, B. (2010) Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J. Clin. Invest. 120, 2355-2369
25. Sanz, P. (2008) AMP-activated protein kinase. Structure and regulation. Curr. Protein Pept. Sci. 9, 478-492
26. Müller, B. A. (2009) Imatinib and its successors. How modern chemistry has changed drug development. Curr. Pharm. Des. 15, 120-133
27. Druker, B. J. (2008) Translation of the Philadelphia chromosome into therapy for CML. Blood 112, 4808-4817
28. Wen, S. T., and Van Etten, R. A. (1997) The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity. Genes Dev. 11, 2456-2467
29. Prospéri, M. T., Ferbus, D., Rouillard, D., and Goubin, G. (1998) The pag gene product, a physiological inhibitor of c-abl tyrosine kinase, is overexpressed in cells entering S phase and by contact with agents inducing oxidative stress. FEBS Lett. 423, 39-44 (Pubitemid 28098575)
30. Cao, J., Schulte, J., Knight, A., Leslie, N. R., Zagozdzon, A., Bronson, R., Manevich, Y., Beeson, C., and Neumann, C. A. (2009) Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity. EMBO J. 28, 1505-1517
31. Morell, M., Espargaró, A., Avilés, F. X., and Ventura, S. (2007) Detection of transient protein-protein interactions by bimolecular fluorescence complementation. The Abl-SH3 case. Proteomics 7, 1023-1036 (Pubitemid 46649152)
32. Wong, C. M., Zhou, Y., Ng, R. W., Kung Hf, H. F., and Jin, D. Y. (2002) Cooperation of yeast peroxiredoxins Tsa1p and Tsa2p in the cellular defense against oxidative and nitrosative stress. J. Biol. Chem. 277, 5385-5394 (Pubitemid 34968585)
33. Levine, Y. C., Li, G. K., and Michel, T. (2007) Agonist-modulated regulation of AMP-activated protein kinase (AMPK) in endothelial cells. Evidence for an AMPK 3 Rac1 3 Akt 3 endothelial nitric-oxide synthase pathway. J. Biol. Chem. 282, 20351-20364 (Pubitemid 47100039)
34. Wang, F., Song, X., Zhou, M., Wei, L., Dai, Q., Li, Z., Lu, N., and Guo, Q. (2013) Wogonin inhibits H2O2-induced vascular permeability through suppressing the phosphorylation of caveolin-1. Toxicology 305, 10-19
35. Rothberg, K. G., Heuser, J. E., Donzell, W. C., Ying, Y. S., Glenney, J. R., and Anderson, R. G. (1992) Caveolin, a protein component of caveolae membrane coats. Cell 68, 673-682
36. Glenney, J. R., Jr., and Soppet, D. (1992) Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 89, 10517-10521
37. Ko, Y. G., Liu, P., Pathak, R. K., Craig, L. C., and Anderson, R. G. (1998) Early effects of pp60(v-src) kinase activation on caveolae. J. Cell. Biochem. 71, 524-535 (Pubitemid 28521007)
38. Sun, S. W., Zu, X. Y., Tuo, Q. H., Chen, L. X., Lei, X. Y., Li, K., Tang, C. K., and Liao, D. F. (2010) Caveolae and caveolin-1 mediate endocytosis and transcytosis of oxidized low density lipoprotein in endothelial cells. Acta Pharmacol. Sin. 31, 1336-1342
39. Kumar, S., Mishra, N., Raina, D., Saxena, S., and Kufe, D. (2003) Abrogation of the cell death response to oxidative stress by the c-Abl tyrosine kinase inhibitor STI571. Mol. Pharmacol. 63, 276-282 (Pubitemid 36158362)
40. Cao, H., Courchesne, W. E., and Mastick, C. C. (2002) A phosphotyrosine-dependent protein interaction screen reveals a role for phosphorylation of caveolin-1 on tyrosine 14. Recruitment of C-terminal Src kinase. J. Biol. Chem. 277, 8771-8774 (Pubitemid 34952941)
41. Ceolotto, G., Gallo, A., Papparella, I., Franco, L., Murphy, E., Iori, E., Pagnin, E., Fadini, G. P., Albiero, M., Semplicini, A., and Avogaro, A. (2007) Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism. Arterioscler. Thromb. Vasc. Biol. 27, 2627-2633 (Pubitemid 350158915)
42. Deng, G., Long, Y., Yu, Y. R., and Li, M. R. (2010) Adiponectin directly improves endothelial dysfunction in obese rats through the AMPK-eNOS Pathway. Int. J. Obes. (Lond.) 34, 165-171
43. Lassila, M., Allen, T. J., Cao, Z., Thallas, V., Jandeleit-Dahm, K. A., Candido, R., and Cooper, M. E. (2004) Imatinib attenuates diabetes-associated atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 24, 935-942 (Pubitemid 38620875)
44. Hägerkvist, R., Makeeva, N., Elliman, S., and Welsh, N. (2006) Imatinib mesylate (Gleevec) protects against streptozotocin-induced diabetes and islet cell death in vitro. Cell Biol. Int. 30, 1013-1017 (Pubitemid 44781307)
45. Hägerkvist, R., Sandler, S., Mokhtari, D., and Welsh, N. (2007) Amelioration of diabetes by imatinib mesylate (Gleevec). Role of β-cell NF-κB activation and anti-apoptotic preconditioning. FASEB J. 21, 618-628 (Pubitemid 46213508)
46. Louvet, C., Szot, G. L., Lang, J., Lee, M. R., Martinier, N., Bollag, G., Zhu, S., Weiss, A., and Bluestone, J. A. (2008) Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice. Proc. Natl. Acad. Sci. U.S.A. 105, 18895-18900
47. Jeyabalan, J., Shah, M., Viollet, B., and Chenu, C. (2012) AMP-activated protein kinase pathway and bone metabolism. J. Endocrinol. 212, 277-290
48. Gayard, M., Guilluy, C., Rousselle, A., Viollet, B., Henrion, D., Pacaud, P., Loirand, G., and Rolli-Derkinderen, M. (2011) AMPK α1-induced RhoA phosphorylation mediates vasoprotective effect of estradiol. Arterioscler. Thromb. Vasc. Biol. 31, 2634-2642
49. Goirand, F., Solar, M., Athea, Y., Viollet, B., Mateo, P., Fortin, D., Leclerc, J., Hoerter, J., Ventura-Clapier, R., and Garnier, A. (2007) Activation of AMP kinase α1 subunit induces aortic vasorelaxation in mice. J. Physiol. 581, 1163-1171 (Pubitemid 46887985)
50. Bess, E., Fisslthaler, B., Frömel, T., and Fleming, I. (2011) Nitric oxide-induced activation of the AMP-activated protein kinase α2 subunit attenuates IκB kinase activity and inflammatory responses in endothelial cells. PLoS ONE 6, e20848
51. Xing, J., Wang, Q., Coughlan, K., Viollet, B., Moriasi, C., and Zou, M. H. (2013) Inhibition of AMP-activated protein kinase accentuates lipopolysaccharide-induced lung endothelial barrier dysfunction and lung injury in vivo. Am. J. Pathol. 182, 1021-1030
52. Warden, S. M., Richardson, C., O'Donnell, J., Jr., Stapleton, D., Kemp, B. E., and Witters, L. A. (2001) Post-translational modifications of the β-1 subunit of AMP-activated protein kinase affect enzyme activity and cellular localization. Biochem. J. 354, 275-283